fm8k-0608.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported) June
24, 2008
(Exact
Name of Registrant as Specified in Its Charter)
(State or
Other Jurisdiction of Incorporation)
333-105075
|
87-0652870
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
|
3293
Harrison Blvd., Ste. 230, Ogden, UT
|
84403
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2.
below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other
Events
On June 24, 2008, Bio-Path Holdings,
Inc., announced that Hans A. de Haan, M.D., Ph.D., F.F.P.M., F.R.C.S., has
joined Bio-Path as its Medical Officer. The press release relating to this
announcement is attached hereto as an exhibit and is incorporated by
reference herein.
Item 9.01 Financial
Statements and Exhibits
Exhibits
|
Exhibit
Number
|
Description
|
|
|
|
|
|
|
99.1
|
Press
Release
|
|
SIGNATURES
Pursuant to the requirements of the
Securities Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
Dated: June
24, 2008
|
BIO-PATH
HOLDINGS INC.
|
|
|
|
By: /s/
Peter Nielsen
|
|
Chief
Executive Officer
|